Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS (London) 2017-01, Vol.31 (3), p.455-457
Hauptverfasser: Bonfanti, Paolo, Madeddu, Giordano, Gulminetti, Roberto, Squillace, Nicola, Orofino, Giancarlo, Vitiello, Paola, Rusconi, Stefano, Celesia, Benedetto M, Maggi, Paolo, Ricci, Elena
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 457
container_issue 3
container_start_page 455
container_title AIDS (London)
container_volume 31
creator Bonfanti, Paolo
Madeddu, Giordano
Gulminetti, Roberto
Squillace, Nicola
Orofino, Giancarlo
Vitiello, Paola
Rusconi, Stefano
Celesia, Benedetto M
Maggi, Paolo
Ricci, Elena
description
doi_str_mv 10.1097/QAD.0000000000001351
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1858104873</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1858104873</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3980-37ec9f006aa629198ce19b54238b803cc9caace089f52453a9a1fa15686829ff3</originalsourceid><addsrcrecordid>eNpdkEtPwzAQhC0EouXxDxDKkUvKOo4T-4h4VqqEkOActu6GBtK42E4r_j2G8hJ7WWk036x2GDviMOKgy9O7s4sR_BkuJN9iQ56XIpWy5NtsCFmhUy1KGLA975-jSYJSu2yQKSi1zPMhe7xovLFdaLoeQ2O7xNZJcIRhQV1IsJslOFuR85TQKio-abqoJuOAbRO3sXPrwge0jPinIWbMbNsHenK4atwB26mx9XT4tffZw9Xl_flNOrm9Hp-fTVIjtIJUlGR0DVAgFpnmWhnieirzTKipAmGMNoiGQOlaZrkUqJHXyGWhCpXpuhb77GSTu3T2tScfqkX8jNoWO7K9r7iSikOuShGt-cZqnPXeUV0tXbNA91ZxqD66rWK31f9uI3b8daGfLmj2A32X-Zu7tm2Inb20_ZpcNSdsw_wzLwMBaQa8BB6pdKO8A_0vhIA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1858104873</pqid></control><display><type>article</type><title>Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Bonfanti, Paolo ; Madeddu, Giordano ; Gulminetti, Roberto ; Squillace, Nicola ; Orofino, Giancarlo ; Vitiello, Paola ; Rusconi, Stefano ; Celesia, Benedetto M ; Maggi, Paolo ; Ricci, Elena</creator><creatorcontrib>Bonfanti, Paolo ; Madeddu, Giordano ; Gulminetti, Roberto ; Squillace, Nicola ; Orofino, Giancarlo ; Vitiello, Paola ; Rusconi, Stefano ; Celesia, Benedetto M ; Maggi, Paolo ; Ricci, Elena ; CISAI Study group</creatorcontrib><identifier>ISSN: 0269-9370</identifier><identifier>EISSN: 1473-5571</identifier><identifier>DOI: 10.1097/QAD.0000000000001351</identifier><identifier>PMID: 28079544</identifier><language>eng</language><publisher>England: Copyright Wolters Kluwer Health, Inc</publisher><subject>AIDS/HIV ; Cohort Studies ; Heterocyclic Compounds, 3-Ring ; HIV Infections ; HIV Integrase Inhibitors ; Humans</subject><ispartof>AIDS (London), 2017-01, Vol.31 (3), p.455-457</ispartof><rights>Copyright © 2017 Wolters Kluwer Health, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3980-37ec9f006aa629198ce19b54238b803cc9caace089f52453a9a1fa15686829ff3</citedby><cites>FETCH-LOGICAL-c3980-37ec9f006aa629198ce19b54238b803cc9caace089f52453a9a1fa15686829ff3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28079544$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bonfanti, Paolo</creatorcontrib><creatorcontrib>Madeddu, Giordano</creatorcontrib><creatorcontrib>Gulminetti, Roberto</creatorcontrib><creatorcontrib>Squillace, Nicola</creatorcontrib><creatorcontrib>Orofino, Giancarlo</creatorcontrib><creatorcontrib>Vitiello, Paola</creatorcontrib><creatorcontrib>Rusconi, Stefano</creatorcontrib><creatorcontrib>Celesia, Benedetto M</creatorcontrib><creatorcontrib>Maggi, Paolo</creatorcontrib><creatorcontrib>Ricci, Elena</creatorcontrib><creatorcontrib>CISAI Study group</creatorcontrib><title>Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir</title><title>AIDS (London)</title><addtitle>AIDS</addtitle><subject>AIDS/HIV</subject><subject>Cohort Studies</subject><subject>Heterocyclic Compounds, 3-Ring</subject><subject>HIV Infections</subject><subject>HIV Integrase Inhibitors</subject><subject>Humans</subject><issn>0269-9370</issn><issn>1473-5571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkEtPwzAQhC0EouXxDxDKkUvKOo4T-4h4VqqEkOActu6GBtK42E4r_j2G8hJ7WWk036x2GDviMOKgy9O7s4sR_BkuJN9iQ56XIpWy5NtsCFmhUy1KGLA975-jSYJSu2yQKSi1zPMhe7xovLFdaLoeQ2O7xNZJcIRhQV1IsJslOFuR85TQKio-abqoJuOAbRO3sXPrwge0jPinIWbMbNsHenK4atwB26mx9XT4tffZw9Xl_flNOrm9Hp-fTVIjtIJUlGR0DVAgFpnmWhnieirzTKipAmGMNoiGQOlaZrkUqJHXyGWhCpXpuhb77GSTu3T2tScfqkX8jNoWO7K9r7iSikOuShGt-cZqnPXeUV0tXbNA91ZxqD66rWK31f9uI3b8daGfLmj2A32X-Zu7tm2Inb20_ZpcNSdsw_wzLwMBaQa8BB6pdKO8A_0vhIA</recordid><startdate>20170128</startdate><enddate>20170128</enddate><creator>Bonfanti, Paolo</creator><creator>Madeddu, Giordano</creator><creator>Gulminetti, Roberto</creator><creator>Squillace, Nicola</creator><creator>Orofino, Giancarlo</creator><creator>Vitiello, Paola</creator><creator>Rusconi, Stefano</creator><creator>Celesia, Benedetto M</creator><creator>Maggi, Paolo</creator><creator>Ricci, Elena</creator><general>Copyright Wolters Kluwer Health, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170128</creationdate><title>Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir</title><author>Bonfanti, Paolo ; Madeddu, Giordano ; Gulminetti, Roberto ; Squillace, Nicola ; Orofino, Giancarlo ; Vitiello, Paola ; Rusconi, Stefano ; Celesia, Benedetto M ; Maggi, Paolo ; Ricci, Elena</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3980-37ec9f006aa629198ce19b54238b803cc9caace089f52453a9a1fa15686829ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>AIDS/HIV</topic><topic>Cohort Studies</topic><topic>Heterocyclic Compounds, 3-Ring</topic><topic>HIV Infections</topic><topic>HIV Integrase Inhibitors</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bonfanti, Paolo</creatorcontrib><creatorcontrib>Madeddu, Giordano</creatorcontrib><creatorcontrib>Gulminetti, Roberto</creatorcontrib><creatorcontrib>Squillace, Nicola</creatorcontrib><creatorcontrib>Orofino, Giancarlo</creatorcontrib><creatorcontrib>Vitiello, Paola</creatorcontrib><creatorcontrib>Rusconi, Stefano</creatorcontrib><creatorcontrib>Celesia, Benedetto M</creatorcontrib><creatorcontrib>Maggi, Paolo</creatorcontrib><creatorcontrib>Ricci, Elena</creatorcontrib><creatorcontrib>CISAI Study group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>AIDS (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bonfanti, Paolo</au><au>Madeddu, Giordano</au><au>Gulminetti, Roberto</au><au>Squillace, Nicola</au><au>Orofino, Giancarlo</au><au>Vitiello, Paola</au><au>Rusconi, Stefano</au><au>Celesia, Benedetto M</au><au>Maggi, Paolo</au><au>Ricci, Elena</au><aucorp>CISAI Study group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir</atitle><jtitle>AIDS (London)</jtitle><addtitle>AIDS</addtitle><date>2017-01-28</date><risdate>2017</risdate><volume>31</volume><issue>3</issue><spage>455</spage><epage>457</epage><pages>455-457</pages><issn>0269-9370</issn><eissn>1473-5571</eissn><cop>England</cop><pub>Copyright Wolters Kluwer Health, Inc</pub><pmid>28079544</pmid><doi>10.1097/QAD.0000000000001351</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-9370
ispartof AIDS (London), 2017-01, Vol.31 (3), p.455-457
issn 0269-9370
1473-5571
language eng
recordid cdi_proquest_miscellaneous_1858104873
source MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals
subjects AIDS/HIV
Cohort Studies
Heterocyclic Compounds, 3-Ring
HIV Infections
HIV Integrase Inhibitors
Humans
title Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T11%3A15%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discontinuation%20of%20treatment%20and%20adverse%20events%20in%20an%20Italian%20cohort%20of%20patients%20on%20dolutegravir&rft.jtitle=AIDS%20(London)&rft.au=Bonfanti,%20Paolo&rft.aucorp=CISAI%20Study%20group&rft.date=2017-01-28&rft.volume=31&rft.issue=3&rft.spage=455&rft.epage=457&rft.pages=455-457&rft.issn=0269-9370&rft.eissn=1473-5571&rft_id=info:doi/10.1097/QAD.0000000000001351&rft_dat=%3Cproquest_cross%3E1858104873%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1858104873&rft_id=info:pmid/28079544&rfr_iscdi=true